MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: KleidungDarkweb mixerAntwortenAntworten: Darkweb mixer <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 15:05 Uhr</div>[url=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/]Zoya Demidenko[/url]: Researcher in Tumor Biology [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053]Zoya Demidenko[/url] is a recognized scholar associated with the Division of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Before that, she worked at the NIH and New York Medical College, developing a strong base in biomedical investigation. Demidenko's scientific contributions spans a number of critical areas, among them the PI3K/AKT/mTOR molecular pathway, cell cycle control, cellular aging, and cancer science. Currently, she has co-authored over 46 scientific articles, which have accumulated more than 4,100 mentions — a reflection to the influence of her findings. Among her key achievements concerns explaining the mechanisms of cellular senescence. Her work demonstrated that when the cellular division cycle is halted but cellular expansion continues, cells enter senescence. Crucially, [url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126]Zoya Demidenko[/url] established that this transition is controlled with drugs using agents such as rapamycin. [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053]Zoya Demidenko[/url] has furthermore contributed substantially to oncological therapy research, particularly in the field of cyclotherapy — a method designed to shielding normal cells from anticancer drugs while leaving malignant cells susceptible. This approach offers considerable hope for diminishing the toxic effects of oncological therapy. Throughout her professional journey, Demidenko has partnered with leading researchers internationally, including Dr. Mikhail Blagosklonny. Her research appears in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: With an h-index of 33, [url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126]Zoya Demidenko[/url] is recognized as a influential figure in contemporary oncological research, with her discoveries go on to influence our knowledge of how cells age, interact with treatment, and the ways in which malignant disease may be more successfully treated. https://moodylab.smhs.gwu.edu/lab-members</blockquote><br> Abbrechen
